You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent lymphoblastic lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 22, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Dec 13, 2022

      Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +15 more
      • Anti-CD19/CD20/CD22 CAR T-Cells
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 4, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +10 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 21, 2022

      Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

      Completed
      Has Results
      • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
      • Recurrent Childhood B-Lymphoblastic Lymphoma
      • San Diego, California
      • +2 more
      Sep 13, 2022

      Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia Trial

      Not yet recruiting
      • Recurrent Acute Myeloid Leukemia
      • +7 more
      • Anti-CD123 ADC IMGN632
      • +7 more
      • (no location specified)
      Dec 28, 2022

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

      Not yet recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +5 more
      • Interferon Beta-1A
      • +10 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 6, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • CD7 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 11, 2022

      Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

      Completed
      • Acute Lymphoblastic Leukemia
      • CAR-NK-CD19 Cells
      • Sanhe, Hebei, China
        Hebei Yanda Ludaopei Hospital
      Nov 24, 2022

      Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

      Terminated
      • Acute Myelogenous Leukemia
      • +2 more
      • Oklahoma City, Oklahoma
      • +1 more
      Mar 17, 2022

      B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

      Active, not recruiting
      • B-Cell Acute Lymphoblastic Leukemia, Adult
      • +2 more
      • Maywood, Illinois
        Loyola University
      Aug 11, 2022

      Blasts 5 Percent or More of Bone Marrow Nucleated Cells, CD22 Positive, Philadelphia Chromosome Positive Trial in Monrovia,

      Recruiting
      • Blasts 5 Percent or More of Bone Marrow Nucleated Cells
      • +4 more
      • ADCT-602
      • Monrovia, California
      • +1 more
      Dec 7, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • São Paulo, Brazil
        Hospital Israelita Albert Einstein
      Jan 20, 2023

      Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

      Recruiting
      • Recurrent Acute Leukemia
      • +16 more
      • Duarte, California
        City of Hope Medical Center
      Nov 22, 2022

      B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric, Lymphoma Trial in Stanford (Fludarabine, Cyclophosphamide, Autologous

      Suspended
      • B Cell Lymphoma
      • +2 more
      • Stanford, California
        Stanford Medical Center
      Sep 8, 2022

      Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

      Completed
      • Childhood Acute Lymphoblastic Leukemia in Remission
      • Recurrent Childhood Acute Lymphoblastic Leukemia
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Aug 12, 2022

      Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

      Terminated
      Has Results
      • Acute Biphenotypic Leukemia
      • +29 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 4, 2023

      Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +2 more
      • RD13-02 cell infusion
      • Xuzhou, Jiangsu, China
        Affiliated hospital of Xuzhou medical college
      Jun 7, 2023

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      Has Results
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +20 more
      • Scottsdale, Arizona
      • +1 more
      May 6, 2022

      Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

      Active, not recruiting
      • Adult Lymphocyte Depletion Hodgkin Lymphoma
      • +16 more
      • 6,8-bis(benzylthio)octanoic acid
      • bendamustine hydrochloride
      • Winston-Salem, North Carolina
      • +1 more
      Apr 8, 2022